Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Astermark

Showing results (41-50 of 79) with videos related to

Pageof 8
Sort By:
Haemophilia : the Official Journal of the World Federation of Hemophilia|January 16, 2008
Value added: increasing the power to assess treatment outcome in joint haemorrhagesS M Donfield, J Astermark, A E Lail, et al.
Thrombosis Research|July 19, 2000
Correlation between different intensities of anti-vitamin K treatment and coagulation parametersA Jerkeman, J Astermark, U Hedner, et al.
Thrombosis and Haemostasis|January 5, 2002
Complexes between activated protein C and protein C inhibitor measured with a new method: comparison of performance with other markers of hypercoagulability in the diagnosis of deep vein thrombosisK Strandberg, J Astermark, O Björgell, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 27, 2003
Impact of inhibitor epitope profile on the neutralizing effect against plasma-derived and recombinant factor VIII concentrates in vitroJ Astermark, J Voorberg, H Lenk, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 12, 2012
Daily dosing prophylaxis for haemophilia: a randomized crossover pilot study evaluating feasibility and efficacyK Lindvall, J Astermark, S Björkman, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 29, 2012
Malignant disease in the haemophilic population: moving towards a management consensus?J Astermark, M Makris, E Mauser-Bunschoten, et al.
British Journal of Haematology|October 29, 1998
Major surgery seems not to influence HIV disease progression in haemophilia patientsJ Astermark, T Löfqvist, S Schulman, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 5, 2013
Incidence, mortality rates and causes of deaths in haemophilia patients in SwedenS Lövdahl, K M Henriksson, F Baghaei, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|January 20, 2009
Thrombin generation assay: a useful routine check-up tool in the management of patients with haemophilia?G L Salvagno, J Astermark, G Lippi, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|May 11, 1999
The proportion of carboxylated to total or intact osteocalcin in serum discriminates warfarin-treated patients from control subjectsK J Obrant, S M Käkönen, J Astermark, et al.
Pageof 8

Showing results (41-50 of 79) with videos related to

Sort By:
Pageof 8
Haemophilia : the Official Journal of the World Federation of Hemophilia|January 16, 2008
Value added: increasing the power to assess treatment outcome in joint haemorrhagesS M Donfield, J Astermark, A E Lail, et al.
Thrombosis Research|July 19, 2000
Correlation between different intensities of anti-vitamin K treatment and coagulation parametersA Jerkeman, J Astermark, U Hedner, et al.
Thrombosis and Haemostasis|January 5, 2002
Complexes between activated protein C and protein C inhibitor measured with a new method: comparison of performance with other markers of hypercoagulability in the diagnosis of deep vein thrombosisK Strandberg, J Astermark, O Björgell, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 27, 2003
Impact of inhibitor epitope profile on the neutralizing effect against plasma-derived and recombinant factor VIII concentrates in vitroJ Astermark, J Voorberg, H Lenk, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 12, 2012
Daily dosing prophylaxis for haemophilia: a randomized crossover pilot study evaluating feasibility and efficacyK Lindvall, J Astermark, S Björkman, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 29, 2012
Malignant disease in the haemophilic population: moving towards a management consensus?J Astermark, M Makris, E Mauser-Bunschoten, et al.
British Journal of Haematology|October 29, 1998
Major surgery seems not to influence HIV disease progression in haemophilia patientsJ Astermark, T Löfqvist, S Schulman, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 5, 2013
Incidence, mortality rates and causes of deaths in haemophilia patients in SwedenS Lövdahl, K M Henriksson, F Baghaei, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|January 20, 2009
Thrombin generation assay: a useful routine check-up tool in the management of patients with haemophilia?G L Salvagno, J Astermark, G Lippi, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|May 11, 1999
The proportion of carboxylated to total or intact osteocalcin in serum discriminates warfarin-treated patients from control subjectsK J Obrant, S M Käkönen, J Astermark, et al.
Pageof 8